Current and future biomarkers for risk-stratification and treatment personalisation in multiple myeloma-Reference-Cited by-同舟云学术

Current and future biomarkers for risk-stratification and treatment personalisation in multiple myeloma

Published:2019 Issue:1 Volume:15 Page:7-20
ISSN:2515-4184
Container-title:Molecular Omics
language:en
Short-container-title:Mol. Omics

Author:

Lê Giao N.¹²³⁴⁵^ORCID,Bones Jonathan¹²³^ORCID,Coyne Mark⁶⁷⁸³,Bazou Despina⁶⁷⁸³,Dowling Paul⁹¹⁰¹¹³,O’Gorman Peter⁶⁷⁸³,Larkin Anne-Marie⁴⁵¹²³

Affiliation:

1. NIBRT – The National Institute for Bioprocessing Research and Training

2. Dublin A94 X099

3. Ireland

4. National Institute for Cellular Biotechnology

5. Dublin City University

6. Department of Haematology

7. Mater Misericordiae University Hospital

8. Dublin D07 R2WY

9. Department of Biology

10. National University of Ireland

11. Maynooth

12. Dublin D09 NR58

Abstract

Genomic, proteomic, and glycomic platforms are utilised to improve biomarkers for prognostication and prediction of treatment response in multiple myeloma.

Funder

Health Research Board

Irish Research Council

Publisher

Royal Society of Chemistry (RSC)

Subject

Genetics,Molecular Biology,Biochemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2019/MO/C8MO00193F

Reference132 articles.

1. Remarks on the Pathology of Mollities Ossium. With Cases

2. Case of Mollities and Fragilitas Ossium, Accompanied with Urine Strongly Charged with Animal Matter

3. URETHANE AND STILBAMIDINE IN MULTIPLE MYELOMA *1REPORT ON TWO CASES

4. CLINICAL EXPERIENCES WITH SARCOLYSIN IN NEOPLASTIC DISEASES

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends in Artificial Intelligence Applications in Clinical Trials: An analysis of ClinicalTrials.gov;Korean Journal of Clinical Pharmacy;2024-06-30

2. Multiple Myeloma in the Era of Novel Agents and Stem Cell Therapies;Recent Updates on Multiple Myeloma;2023-03-15

3. DAZAP1 facilitates the alternative splicing of KITLG to promote multiple myeloma cell proliferation via ERK signaling pathway;Aging;2022-10-13

4. Clinical Application of Biomarkers for Hematologic Malignancies;Biomarkers in Medicine;2022-08-30

5. A Bottom-Up Proteomic Approach in Bone Marrow Plasma Cells of Newly Diagnosed Multiple Myeloma Patients;Current Proteomics;2021-11-23